Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Mouse anti-Human IgA2 Antibody (PE)

ELISA Monoclonal A9604D2 IgG1 PE
Catalog No. ABIN376572

Quick Overview for Mouse anti-Human IgA2 Antibody (PE) (ABIN376572)

Target

IgA2

Clonality

  • 11
  • 2
Monoclonal

Conjugate

  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
PE

Application

  • 10
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
ELISA

Clone

A9604D2

Isotype

IgG1
  • Reactivity

    Human

    Host

    • 11
    • 2
    Mouse

    Specificity

    Human IgA2 Fc, Mr 170 kDa

    Characteristics

    Mouse Anti-Human IgA2-PE

    Purification

    Purified

    Immunogen

    Purified human IgA2m(1) myeloma protein
  • Application Notes

    • Applications: ELISA - Quality tested , FLISA - Quality tested ELISPOT - Reported in literature , FC - Reported in literature , IHC-FS - Reported in literature , IHC-PS - Reported in literature , WB - Reported in literature , Multiplex - Reported in literature , Sep - Reported in literature , Depletion - Reported in literature
    • Working Dilutions: ELISA AP conjugate 1:1,000 - 1:2,000 HRP conjugate 1:4,000 - 1:16,000 BIOT conjugate 1:5,000 - 1:10,000 FLISA FITC and AF488 conjugates 1:200 - 1:400 PE and AF647 conjugates ≤ 1 g/mL

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    0.1 mg in 1.0 mL of PBS/Sodium azide and a stabilizing agent

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Do not freeze!
    Protect conjugated products from light.

    Each reagent is stable for the period shown on the bottle label if stored as directed.

    Storage

    4 °C

    Storage Comment

    Store at 2-8°C
  • Violari, Cotton, Kuhn, Schramm, Paximadis, Loubser, Shalekoff, Da Costa Dias, Otwombe, Liberty, McIntyre, Babiker, Gibb, Tiemessen: "A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation." in: Nature communications, Vol. 10, Issue 1, pp. 412, (2019) (PubMed).

  • Target

    IgA2
You are here:
Chat with us!